Leading the Way in Life Science Technologies

GEN Exclusives

More »

Best of the Web

More »
Apr 15, 2007 (Vol. 27, No. 8)

DNA 2.0 Inc. - Bioinformatics Toolbox

  • Useful, easy to access
  • Needs primer functions
My quest for the best free online sequence analysis site continues with DNA 2.0 Inc.’s Bioinformatics Toolbox. First, the toolset is extensive, with groupings of Format Conversion (14 applications), Sequence Analysis (20 applications), Sequence Figures (seven applications), and Random Sequences (six applications). The Sequence Analysis section contains common functions, including codon plots, ORF finder, pairwise alignments, translate, protein molecular weight, and more. Notably absent was a primer prediction tool. The Sequence Figures section had a nice surprise, with two tools for coloring of aligned sequences. The randomizing tools also were a little unusual but obviously useful for determining significance of findings in sequences. Overall, the package wins big for ease of use (pasting sequences in text boxes), but loses a few points for its lack of primer functions.
  • Key:
  • Strong Points
  • Weak Points
  • Ratings:
  • Excellent
  • Very Good
  • Good

*The opinions expressed are solely those of the author(s) and should not be construed as reflecting the viewpoints of the publisher, Genetic Engineering & Biotechnology News, Mary Ann Liebert, Inc., the publishing house, or employees and affiliates thereof.

Be sure to take the GEN Poll

Scientifically Studying Ecstasy

MDMA (commonly known as the empathogen “ecstasy”) is classified as a Schedule 1 drug, which is reserved for compounds with no accepted medical use and a high abuse potential. Two researchers from Stanford, however, call for a rigorous scientific exploration of MDMA's effects to identify precisely how the drug works, the data from which could be used to develop therapeutic compounds.

Do you agree that ecstasy should be studied for its potential therapeutic benefits?

More »